During the past decade, Centro de Diabetes Curitiba conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Diabetes Curitiba" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Diabetes Curitiba" are "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus" (1 trials), "Endocrine System Diseases" (1 trials) and "Glucose Metabolism Disorders" (1 trials). Many other conditions were trialed in "Centro de Diabetes Curitiba" in a lesser frequency.

Most popular intervention types in "Centro de Diabetes Curitiba" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gliclazide MR" (2 trials), "Placebo" (2 trials), "Tirzepatide" (2 trials), "Dapagliflozin" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Diabetes Curitiba" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro de Diabetes Curitiba". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro de Diabetes Curitiba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Diabetes Curitiba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".